Blake Richards is the founder of Elucid. Elucid has raised $121M in total funding. Latest round: Series C. Backed by Elevage Medical Technologies.
Blake Richards is the CEO of Elucid, a Boston-based healthcare technology company that utilizes artificial intelligence to assess cardiovascular disease. Elucid's AI-powered imaging analysis software helps physicians anticipate major adverse cardiac events. The company has raised a total of $121 million, including an $80 million Series C funding round led by Elevage Medical Technologies.
Full founder directory · Investor directory · Company funding database · Fundraising library